INCREASING EFFICIENCY OF VENTILATION IN COVID-19. The Alginate oligosaccharide OligoG CF-5/20 may be an immediate low risk trial Covid-19.

UPDATE: AUSTRALIAN DRUG TRIAL / AlgiPharma AS Immediate available drug for Cystic Fibrosis could be utilized to save lives in Covid-19 crisis.The Alginate oligosaccharide OligoG CF-5/20 may be an immediate low risk trial Covid-19. It is a drug being tested for Cystic Fibrosis. It is currently in Clinical Trials. Can this help in Ventilator Therapy and Decrease Deaths and Time …

Decreasing Mucous Build Up Should Decrease Need Of Respirators For Covid-19 Patients And Increase Survival Rates

Immediate efforts to decrease mucous build-up in infected patients may be the best path forward in decreasing need for advanced emergency medical care and fatalities among CoVid-19 infected patients. We cannot make ventilators fast enough to meet the immediate need and near-term future needs but we can decrease the ultimate need of ventilators. Social Isolation is the single most important …